These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7589823)

  • 1. Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats.
    Yale JF; Lachance D; Bevan AP; Vigeant C; Shaver A; Posner BI
    Diabetes; 1995 Nov; 44(11):1274-9. PubMed ID: 7589823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of peroxovanadium compounds in BB rats.
    Yale JF; Vigeant C; Nardolillo C; Chu Q; Yu JZ; Shaver A; Posner BI
    Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):181-90. PubMed ID: 8927037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanadium compounds as insulin mimics.
    Orvig C; Thompson KH; Battell M; McNeill JH
    Met Ions Biol Syst; 1995; 31():575-94. PubMed ID: 8564818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
    Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
    Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis.
    Bevan AP; Drake PG; Yale JF; Shaver A; Posner BI
    Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):49-58. PubMed ID: 8927047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.
    Posner BI; Faure R; Burgess JW; Bevan AP; Lachance D; Zhang-Sun G; Fantus IG; Ng JB; Hall DA; Lum BS
    J Biol Chem; 1994 Feb; 269(6):4596-604. PubMed ID: 8308031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of impaired glucose tolerance by oral administration of vanadyl sulfate by gavage in streptozotocin-induced diabetic rats.
    Tsunajima T; Tatsuki R; Satoh K; Yamamoto A; Hoshi K; Ichihara K
    Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):190-200. PubMed ID: 9467827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
    Becker DJ; Ongemba LN; Henquin JC
    Eur J Pharmacol; 1994 Aug; 260(2-3):169-75. PubMed ID: 7988641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term bioaccumulation of vanadium when ingested with a tea decoction in streptozotocin-induced diabetic rats.
    Edel AL; Kopilas M; Clark TA; Aguilar F; Ganguly PK; Heyliger CE; Pierce GN
    Metabolism; 2006 Feb; 55(2):263-70. PubMed ID: 16423636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle mitogen-activated protein kinases and ribosomal S6 kinases. Suppression in chronic diabetic rats and reversal by vanadium.
    Hei YJ; Chen X; Pelech SL; Diamond J; McNeill JH
    Diabetes; 1995 Oct; 44(10):1147-55. PubMed ID: 7556949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypoglycemic effects of bis(maltolato)oxovanadium administered by different routes upon diabetic rats].
    Zhong XY; Zhang H; Zhang X; Lv WL; Zhang Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):313-8. PubMed ID: 15205708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
    Yao J; Battell ML; McNeill JH
    Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
    Sakurai H; Fujii K; Watanabe H; Tamura H
    Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of diabetic rats with vanadyl sulfate or insulin attenuate acute focal cerebral ischemia/reperfusion injury via their antiglycemic effect.
    Ahmadi-Eslamloo H; Dehghani GA; Moosavi SMS
    Metab Brain Dis; 2018 Feb; 33(1):225-235. PubMed ID: 29151151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of peroxovanadate complexes on reducing glycemia in diabetic rats and translocation of glucose transporter.
    Yuan M; Yu B; Liang Y
    Chin Med J (Engl); 1997 Sep; 110(9):715-9. PubMed ID: 9642333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral vanadium on glycaemic and lipid profile in rats.
    Hussain Shah SZ; Naveed AK; Rashid A
    J Pak Med Assoc; 2016 Dec; 66(12):1592-1596. PubMed ID: 28179696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypoglycemic effects of peroxovanadate complexes on glucose transportor of diabetic rats].
    Yuan M; Yu B; Liang Y
    Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):208-11. PubMed ID: 9596962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment.
    Wan CK; Giacca A; Matsuhisa M; El-Bahrani B; Lam L; Rodgers C; Shi ZQ
    Metabolism; 2000 Aug; 49(8):984-9. PubMed ID: 10954014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.